SECUGEN is a biotechnology company specialized in the automatic sequencing of DNA and in genetic analysis applied to any discipline of the life sciences. Its goal is to support professionals in this sector and to continue the research and collaboration on new projects.
• General Features
- ACTIVITY: genetic analysis.
- LOCATION: Ramiro de Maeztu Street 9 (28040) Madrid.
- DATE OF ESTABLISHMENT: 2005.
- CATEGORY: small company.
- CONTACT: (+34) 915 338 628
• Business Structure
- N
- NUMBER OF EMPLOYEES: 12.
- REVENUE: ~1,000,000 €
- GENERAL DESCRIPTION: company specialized in DNA sequencing and analysis and its application to any field of life sciences.
- BUSINESS LINES: DNA sequencing, genetic diagnosis, R&D services.
- INFRASTRUCTURE:
- Services:
- DNA sequencing.
- Analysis of microsatellites and fragments.
- DNA purification.
- Genetic and molecular diagnosis.
- Microbial identification, varietal identification, species authentication.
- q-PCR analysis.
- Analysis by immunoassay (ELISA and CLIA).
- R&D services.
- Services:
• R&D Activities/Interests
TECHNOLOGICAL OFFER/DEMAND:
- Development of tailor-made projects.
- Experience in DNA analysis as a genetic marker.
- High sample processing capacity.
• Participation in projects
COMPLETED PROJECTS
- Development of a kit for the diagnosis of mutations and polymorphisms in the human mitochondrial genome. Biotec Cam. 2006-2007 / Community of Madrid.
- Development of a high-performance diagnostic system for the detection of mutations and polymorphisms associated with age-related macular degeneration. Profit 2007-2007 / Ministry of Education and Science.
- Development of a high-performance diagnostic system for detecting mutations and polymorphisms associated with non-syndromic hearing loss. Biotec Cam. 2007-2008 / Community of Madrid.
- The microbial metagenome of the Iberian Peninsula. Consolider 2007-2011 / Ministry of Science and Innovation.
- Development and proof of concept of a high-performance diagnostic system for detecting mutations and polymorphisms associated with age-related macular degeneration. Biotec Cam. 2008-2008 / Community of Madrid.
- Development of new DNA polymerases for amplification, modification, and genetic analysis of DNA. Impacto 2016-2019 / Ministry of Science and Innovation.
- Integrated platform for the molecular diagnosis of diseases related to the complement system. Retos 2016-2019 / European Union and Ministry of Economy, Industry and Competitiveness.